The present invention relates to pharmaceutical compositions containing compounds of formulawhereinRis H, C-alkyl, C-alkyl-C-cycloalkyl, C-haloalkyl;Ris H, C-alkyl;Xis an anion selected from the group consisting of chloride or ½ dibenzoyltartratejis 1 or 2.processes for the preparation thereof, and their use to treat diseases connected with the CCR3 receptor